Literature DB >> 27379946

Update on the biology and management of neuroendocrine prostate cancer.

Himisha Beltran1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27379946

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  6 in total

1.  [Neuroendocrine prostate cancer].

Authors:  S Tritschler; R Erdelkamp; C Stief; M Hentrich
Journal:  Pathologe       Date:  2018-07       Impact factor: 1.011

Review 2.  EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers.

Authors:  Rama Soundararajan; Anurag N Paranjape; Sankar Maity; Ana Aparicio; Sendurai A Mani
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-07-05       Impact factor: 10.680

3.  [Neuroendocrine prostate cancer].

Authors:  S Tritschler; R Erdelkamp; C Stief; M Hentrich
Journal:  Urologe A       Date:  2017-11       Impact factor: 0.639

Review 4.  Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression.

Authors:  Yicheng Zhao; Wenliang Li
Journal:  Asian J Androl       Date:  2019 May-Jun       Impact factor: 3.285

Review 5.  Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers.

Authors:  Rama Soundararajan; Ana M Aparicio; Christopher J Logothetis; Sendurai A Mani; Sankar N Maity
Journal:  Front Oncol       Date:  2018-03-15       Impact factor: 6.244

6.  TMEM59 potentiates Wnt signaling by promoting signalosome formation.

Authors:  Jan P Gerlach; Ingrid Jordens; Daniele V F Tauriello; Ineke van 't Land-Kuper; Jeroen M Bugter; Ivar Noordstra; Johanneke van der Kooij; Teck Y Low; Felipe X Pimentel-Muiños; Despina Xanthakis; Nicola Fenderico; Catherine Rabouille; Albert J R Heck; David A Egan; Madelon M Maurice
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-09       Impact factor: 11.205
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.